Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer
Cancer Chemotherapy and Pharmacology, 05/25/2012Chiorean EG et al.
This neoadjuvant regimen was safe and demonstrated significant antitumor activity. High thymidine phosphorylase (TP) tumor gene expression was associated with obtaining pathological complete response (pCR).
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.